Stocks · NASDAQ · Healthcare · United States
BNTX — BioNTech SE
BioNTech SE (BNTX) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 98.57 (-0.51% on the day), -3.0% over one month, +5.0% over three months, +0.5% over twelve months. The InvestMuse composite score is -17 on a −100 to +100 scale, a mixed read that ranks #865 of about 1,221 assets. The strongest of its nine dimensions are Regime (hidden Markov model) (+30) and Trend (+28); the weakest is Sector edge (-100). Its volatility regime from the hidden Markov model is Hot. 21 news articles in the last 30 days carried an average tone of +0.06 (on −1 to +1).
The facts
| Last close | 98.57 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -0.51% / -3.0% / +5.0% / +0.5% |
| 52-week range | 83.89 – 119.34 |
| Composite score | -17 / 100 · mixed view · rank #865 |
| Volatility regime (HMM) | Hot |
| Resistance levels | 100.00 |
| Market cap | $23.6B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)+30
- Technical indicators-11
- Trend+28
- Support / resistance-2
- Fundamentals-43
- Sector edge-100
- News sentiment+6
- Momentum+7
- Chart patterns and zones+15
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.